| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LUNG | Exit | PULMONX CORP | $0 | – | -60,204 | -100.0% | -2.98% | – |
| Exit | RAPID MICRO BIOSYSTEMS INC | $0 | – | -1,038,296 | -100.0% | -5.38% | – | |
| MDVL | Exit | MEDAVAIL HOLDINGS INC | $0 | – | -300,588 | -100.0% | -8.66% | – |
| Exit | RAYZEBIO INC | $0 | – | -778,922 | -100.0% | -82.98% | – |
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MEDAVAIL HOLDINGS INC | 12 | Q3 2023 | 92.0% |
| PULMONX CORP | 12 | Q3 2023 | 49.0% |
| RAPID MICRO BIOSYSTEMS INC | 7 | Q3 2023 | 57.2% |
| RAYZEBIO INC | 1 | Q3 2023 | 83.0% |
View ABG-WTT Global Life Science Capital Partners GP Ltd's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 4 | 2023-06-21 |
| 13F-HR | 2023-05-15 |
| 4 | 2023-03-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View ABG-WTT Global Life Science Capital Partners GP Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.